TRPV3 and hearing loss disorder: FPP is an endogenous activator of transient receptor potential cation channel, vanilloid type (TRPV) 3 (Bang et al., 2010), and TRPV3 deficiency protects against kanamycin-induced hearing loss (Wang et al., 2019).